ABSTRACT
The postanaesthetic visit 24 hours after total hip replacement should encompass a clinical assessment of the patient as well as a review of laboratory investigations and the drug prescription chart.
Patients presenting for total hip replacement are often elderly and have coexisting diseases with increased risk of deep vein thrombosis (DVT) and pulmonary embolus, increased risk of pneumonia and, thus, increased overall mortality.
